---
title: "Bridging Olink^®^ Explore 3072 to Olink^®^ Explore HT"
output: 
  rmarkdown::html_vignette:
    toc: true
    toc_depth: 3
    fig_caption: TRUE
    includes:
      in_header: ../man/figures/logo.html
vignette: >
  %\VignetteIndexEntry{Bridging Olink^®^ Explore 3072 to Olink^®^ Explore HT}
  %\VignetteEncoding{UTF-8}
  %\VignetteEngine{knitr::rmarkdown}
date: 'Compiled: `r format(Sys.Date(), "%B %d, %Y")`'
editor_options: 
  markdown: 
    wrap: 72
---

```{r, include = FALSE}
knitr::opts_chunk$set(
  collapse = TRUE,
  comment = "#>",
  tidy = FALSE,
  tidy.opts = list(width.cutoff = 95),
  fig.width = 6,
  fig.height = 3,
  message = FALSE,
  warning = FALSE,
  time_it = TRUE,
  fig.align = "center"
)
```

```{r, echo=FALSE, eval = TRUE}
library(OlinkAnalyze)
library(dplyr)
library(stringr)
library(ggplot2)
library(kableExtra)
```

## Introduction

Individual Olink^®^ NPX^TM^ projects are generally normalized using
either plate control normalization or intensity normalization methods.
Since NPX is a relative measurement, in the case when a study is
separated into multiple projects, an additional normalization step is
needed to allow the data to be comparable across projects. The following tutorial is
designed to give you an overview of the Olink bridging procedure for
combining data sets from Olink^®^ Explore 3072 and Olink^®^ Explore HT
products.

### Important Terminology

-   **Bridging samples** – Overlapping samples run on two or more projects
    that are used as references to enable normalization. These
    samples are selected as described in the [Introduction to Bridging
    tutorial](bridging_introduction.html)
    to ensure samples are of high quality and span the range of the
    data. In the case of data containing LOD, samples are also filtered
    for high detectability. Bridging samples are selected from the project
    that is run first to run with the second project.

-   **Project** – A set of plates that run at the same time and have been normalized together. If two projects are not randomized or are run at different times then additional normalization is required.

-   **Project effect/correction** – As NPX is a relative quantification,
    overall NPX values may shift across projects. This can result in
    separation of projects that are part of the same study which can be
    corrected for using normalization or accounted for within a
    statistical model.
    
-   **Within-product bridging** – Normalization of two or more projects
    run on the same Olink product using bridging samples

-   **Between-product bridging** - Normalization of two or more projects
    from different Olink products (in this case, Olink Explore 3072 and
    Olink Explore HT) using bridging samples

-   **Reference data** – The project data which is being normalized to
    is known as the reference data. In the case of between-product
    bridging, the reference project is the Explore HT NPX data. The
    reference data set is not altered during bridging and the other data
    set is adjusted to the reference data set using the bridging samples.

### Within- and between-product bridging

The joint analysis of two or more NPX projects run on the same Olink
product often requires a project correction step to remove
technical variation. One such method of normalizing two projects is referred to as bridge sample reference
normalization, bridge normalization, or just simply bridging. For more
information on within-product bridging, see the [Introduction to
Bridging
tutorial](bridging_introduction.html).
Bridging makes certain assumptions on the distributions of
the assays, namely that we are measuring the same true biological range
no matter the setting. If an assay displays different distributions
between projects, then both bridging and downstream statistical
analysis will be affected. Within a product, we assume the variance and
shape of the distribution remains constant within assays.

In the case where a study consists of separate projects run on Olink
Explore 3072 and Olink Explore HT, an additional project correction step
is required to allow data from these two products to be analyzed
together, which is referred to as between-product bridging, or Olink
Explore 3072 to Olink Explore HT bridging. Olink Explore 3072 and Olink
Explore HT are both products that use PEA technology combined with next
generation sequencing to calculate NPX for thousands of proteins.
However, assays may vary more between products then within a product, and fewer assumptions
can be made regarding the similarity of assay distributions and
variance between products.

Since many of the assays profiled in Olink Explore 3072 are also found
on Olink Explore HT, bridging data across products enables increased
power in studies consisting of both Explore 3072 and Explore HT data
sets, rather than limiting these studies to meta-analysis. However, differences between products, such as the
number of assays being measured and the reagents being used, can sometimes lead to signal in one product and noise in
another product. Bridging signal to noise can have detrimental effects
on downstream statistical analysis. This means that while some assays
will be able to be bridged using the same method as in within-product
bridging, others will require a different normalization method, and some
will not be bridgeable at all.This normalization strategy combines
median-centering (as is used in within-product bridging) and quantile
smoothing to normalize assays across products based on the assumption
that assays can be bridged provided they have signal in both products or
noise in both products.

### Considerations for between-product bridging

Product bridging allows the NPX values of an Olink Explore 3072 project
to be normalized and made comparable to the NPX values of an Olink
Explore HT project. This process is one-directional, and normalizing
Olink Explore HT NPX values to Olink Explore 3072 is not supported.

The product bridging normalization uses the **\~**2900 assays that are
overlapping between Olink Explore 3072 and Olink Explore HT. Each
overlapping assay undergoes a series of checks that evaluate the number
of counts, correlation, and difference of NPX ranges between the two
data sets. If an assay has enough counts and comparable metrics between
the two data sets, it is determined to be suitable for bridging
(referred to as a "bridgeable assay"). Assays that are not suitable for bridging can either be excluded from downstream analysis in one or both products or results can be integrated across products using meta-analysis. The set of bridgeable assays
across products will vary from data set to data set, based on the
samples present within the studies. Depending on the NPX distribution of
each bridgeable assay in the two data sets, the assay is normalized
using either median normalization or quantile smoothing.

Bridging an Explore 3072 data set to an Explore HT NPX data set
requires 40 - 64 bridging samples. Bridging samples are shared samples
among data sets and, as such, are analyzed in both data sets. Olink NPX
data sets without shared samples cannot be combined using the
bridging approach described below. More information on bridge sample
selection can be found in the [selecting bridging samples
section](bridging_introduction.html#selecting-bridging-samples)
of the Introduction to Bridging tutorial.

## Bridge Sample Selection

Prior to running a study with Explore HT, bridging samples must be selected
from the study run with Explore 3072 and be run on the Explore HT study. These samples can
be selected using the `olink_bridgeselector()` function in Olink Analyze
as detailed in [the Introduction to bridging
tutorial](bridging_introduction.html#selecting-bridging-samples). The recommended number of bridge samples for within- and between- product bridging is summarized in the table below. When selecting bridge samples, the aim is to select samples that represent the dynamic range of the assay expression in the product. As such, quality control of the sample and, if available, proportion of data above LOD in the sample are considered when determining if a sample is chosen as a bridging sample. When LOD data is not available in the data export from Olink NPX software, LOD can optionally be calculated from fixed LOD or negative controls as
detailed in the [Calculating LOD from Olink Explore data
tutorial](LOD.html).

```{r brnrtab, eval=TRUE, message=FALSE, echo = FALSE}
data.frame(Platform = c("Target 96",
                        paste0("Explore 384: \n",
                               "Cardiometabolic, Inflammation, ",
                               "Neurology, and Oncology"),
                        paste0("Explore 384: \n",
                               "Cardiometabolic II, Inflammation II,",
                               "Neurology II, and Oncology II"),
                        "Explore HT",
                        "Explore 3072 to Explore HT"),
           BridgingSamples = c("8-16",
                               "8-16",
                               "16-24",
                               "16-32",
                               "40-64")) |>
  kbl(booktabs = TRUE,
      digits = 2,
      caption = "Recommended number of bridging samples for Olink platforms") |>
  kable_styling(bootstrap_options = "striped",
                full_width = FALSE,
                position = "center",
                latex_options = "HOLD_position")

```



## Workflow Overview

Olink Explore 3072 to Olink Explore HT bridging requires Explore 3072
data and Explore HT data which have at least 40 to 64 bridging samples. For
studies containing multiple projects of Explore 3072 data, the Explore
3072 data sets should be bridged using within-product bridging as
detailed in the [Introduction to bridging
tutorial](bridging_introduction.html) or otherwise normalized together
prior to performing between-product bridging.

The assays from Explore 3072 are matched to the corresponding assays in
Explore HT and evaluated to determine if the assay is bridgeable. Additionally, all assays are normalized using both quantile smoothing and
normalization using the median of paired differences. The result is an
adjusted Explore 3072 data set with five additional columns. Three of these columns relate to bridging normalization:

-   `BridgingRecommendation`: a flag which indicates if the assay is
    bridgeable and, if so, which normalization method is recommended

-   `MedianCenteredNPX`: NPX values after normalization using the median
    of paired differences

-   `QSNormalizedNPX`: NPX values after normalization using quantile
    smoothing
    
Data from Explore 3072 and Explore HT will be concatenated in the function export. Two additional columns are added to aid in data mapping and export. 

-   `Project`: the name of the project as define in the function input

-   `OlinkID_E3072`: mapped Olink IDs from Explore 3072. Olink IDs from Explore HT will be listed in the `OlinkID` column.
    
Note that regardless of the bridging recommendation, NPX values will be
available for both normalization methods. A visual representation of the between-product bridging workflow is shown below.

```{r, fig.cap= fcap, eval = TRUE, echo = FALSE, out.width="50%"}
knitr::include_graphics(normalizePath("../man/figures/Bridging_schematic.png"),
                        error = FALSE)
fcap <- "Schematic of Explore 3072 to Explore HT Bridging Workflow"
```

## Import NPX files

To normalize Explore 3072 data to Explore HT data, first the two data
sets are read into R using `read_NPX()`. If more than two data sets are
being normalized, all Explore 3072 studies should be normalized together
prior to normalizing between products and the concatenated bridged data
set should be used as the input. In the case of multiple Explore HT
studies, only one Explore HT study should be chosen as the reference
data set. The data can be loaded using `read_NPX()` function with
default Olink Software NPX file as input, as shown below.

```{r message=FALSE, eval=FALSE, echo = TRUE}
# Note: Explore 3072 NPX files can be CSV or parquet.
data_explore3072 <- read_NPX("~/NPX_Explore3072_location.parquet")
data_exploreht <- read_NPX("~/NPX_ExploreHT_location.parquet")
```


## Checking input datasets and bridging samples

First, confirm that there are overlapping sample IDs within the study. Note that external controls should not be included in the list of
bridging samples, as detailed in the [Bridge Sample Selection] section
of this tutorial. External control samples often share the same naming
convention across data sets but may represent different samples due to
reagent batch differences. Appending the project name to the end of the
control samples can ensure unique Sample IDs.

```{r, echo=TRUE, eval = FALSE}
data_explore3072_samples <- data_explore3072 |>
  dplyr::filter(SampleType == "SAMPLE") |>
  dplyr::distinct(SampleID) |>
  dplyr::pull()

data_exploreht_samples <- data_exploreht |>
  dplyr::filter(SampleType == "SAMPLE") |>
  dplyr::distinct(SampleID) |>
  dplyr::pull()

overlapping_samples <- unique(intersect(data_explore3072_samples,
                                        data_exploreht_samples))
# Note that if `SampleType` is not is input data:
# stringr::str_detect can be used to exclude control samples based on SampleID.
```

```{r echo=FALSE}
try(
  readRDS(normalizePath("../man/figures/overlapping_samples_table.rds")) |> 
    kableExtra::kbl(booktabs = TRUE,
                    digits = 2,
                    caption = "Overlapping bridging samples") |>
    kableExtra::kable_styling(bootstrap_options = "striped",
                              full_width = FALSE,
                              position = "center",
                              latex_options = "HOLD_position")
)
```


PCA plots for each dataset can be used to assess if any bridge samples are outliers in the dataset.

```{r include=FALSE}
f3 <- paste0("PCA plot prior to bridging for Explore 3072 and Explore HT data.",
             " Bridge samples are indicated by color.",
             " PCA plots can be helpful in assessing",
             " if any bridge samples were outliers in one of the platforms.")
```


```{r eval = FALSE}
#### Extract bridging samples

data_explore3072_before_br <- data_explore3072 |>
  dplyr::filter(SampleType == "SAMPLE") |>
  # Note that if `SampleType` is not is input data,
  # stringr::str_detect can be used to exclude control samples
  #  based on naming convention.
  dplyr::mutate(Type = if_else(SampleID %in% overlapping_samples,
                               paste0("Explore 3072 Bridge"),
                               paste0("Explore 3072 Sample")))

data_exploreht_before_br <- data_exploreht |>
  dplyr::filter(SampleType == "SAMPLE") |>
  dplyr::mutate(Type = if_else(SampleID %in% overlapping_samples,
                               paste0("Explore HT Bridge"),
                               paste0("Explore HT Sample")))

### PCA plot
pca_E3072 <- OlinkAnalyze::olink_pca_plot(df = data_explore3072_before_br,
                                         color_g = "Type",
                                         quiet = TRUE)
pca_EHT <- OlinkAnalyze::olink_pca_plot(df = data_exploreht_before_br,
                                        color_g = "Type",
                                        quiet = TRUE)
```

```{r echo=FALSE, fig.cap=f3, fig.height= 8, fig.width= 6}
knitr::include_graphics(normalizePath("../man/figures/PCA_btw_product_before.png"),
                        error = FALSE)

```


## Normalization

The `olink_normalization()` functionality has been expanded and can be used 
to determine which assays are bridgeable and of the bridgeable assays what
normalization method is advised, and to calculate normalized NPX values
for the Explore 3072 (non-reference) project. Normalized NPX values are calculated for
all assays across products as described in the [Workflow Overview] and in
the sections below. Within this function, the bridging recommendations
for each assay are determined and the NPX values are normalized using
the two methods described below.

```{r eval = FALSE}
# Find shared samples
npx_ht <- data_exploreht |>
  dplyr::mutate(Project = "data1") 
npx_3072 <- data_explore3072 |>
  dplyr::mutate(Project = "data2")

npx_br_data <- olink_normalization(df1 = npx_ht, 
                                   df2 = npx_3072,
                                   overlapping_samples_df1 =
                                     overlapping_samples,
                                   df1_project_nr = "Explore HT",
                                   df2_project_nr = "Explore 3072",
                                   reference_project = "Explore HT")
```

### Determining bridging recommendations

For an assay to be bridgeable across products, it must either have signal
in both products or be primarily background signal in both products.
Bridging noise into signal or signal into noise can negatively impact
downstream statistical analysis. To determine if an assay is bridgeable, 
the bridge samples from both products are used to assess the following
criteria:

-   Is there a linear relationship between products?
    -   **Assessing linearity across products:** To determine if there
        is a linear relationship between products for an assay, the
        linear coefficient of determination (R^2^) is calculated using
        Pearson correlation. R^2^ is a measure of how much of the
        variation in the data is explained by the linear function
        compared to just using the mean. In this correlation, counts
        below 10 are excluded due to lack of signal. The R^2^ value is
        calculated and an assay is considered to have a linear
        relationship across products if the R^2^ value is above the
        cutoff. A higher R^2^ value indicates, that for both products,
        the assay is in the linear range. Conversely, a low R^2^ means
        that either one or both assays are in background. The default
        cutoff is set to R^2^ \> 0.8 indicating that at least 80% of the
        variation in the data is explained by the linear function.
-   Are the NPX ranges in the two products similar?
    -   **Assessing similarity of NPX ranges:** To determine if the NPX
        ranges are similar across products, the difference in NPX values
        from the 10% to 90% quantile is calculated for each product,
        excluding data points with counts less than 10. If the
        difference in range of NPX between products is greater than the
        cutoff then the ranges are not considered similar across
        products. Since the NPX values are calculated on the same
        samples, it is expected that an increase in 1 NPX in one product
        would correspond to an increase of 1 NPX in the other product.
        If the ranges are not similar, this suggests that 1 NPX is not
        equivalent across products. By default, the cutoff is set to a
        difference of less than 1 NPX between products.
-   Are there sufficient counts in both products?
    -   **Assessing if there are sufficient counts:** An assay's
        absolute level of counts is important to consider as the
        instruments used to generate NPX values have an inherent noise
        level. To determine if there are sufficient counts in an assay
        for bridging, the median number of counts in both products is
        calculated, excluding data points with less than 10 counts. If
        the median number of counts is less than the cutoff then the
        assay does not have sufficient counts to be used for bridging.
        The default cutoff is set to 150 counts, which is based on the
        count quality control metrics for Explore products.

For assays that are bridgeable, the shape of the NPX distribution is
compared between the two products:

-   **Assessing similarity of NPX distribution across products:** If the
    three criteria outlined above are met then the assay is considered
    bridgeable. Otherwise, bridging is not recommended for that assay.
    If an assay is bridgeable, the similarity of the NPX distribution is
    used to determine which method is recommended for bridging. The
    Kolmogorov-Smirnov test, or KS test, is used to assess the
    similarity of two distributions by calculating the KS statistic,
    which is based on the empirical cumulative distribution function
    (ECDF). Counts below 10 are excluded and the largest difference seen
    in the ECDF becomes the KS statistic. If the KS statistic is above
    the cutoff, the distributions are considered to have different
    shapes. In this case, a median shift is not sufficient to normalize
    the data, and quantile smoothing is recommended. If the distance is
    less than the cutoff, then normalization using the median of paired
    differences is recommended. By default this cutoff difference is set
    to 0.2.

An overview of these criteria is visualized below.

```{r echo=FALSE, fig.cap=fcap, out.width="50%"}
knitr::include_graphics(normalizePath("../man/figures/assay_bridgeability.jpg"), 
                        error = FALSE)
fcap <- paste("Criteria to determine the bridging recommendation for an assay.",
"The assessment of linearity ensures bridging between signal in both platforms",
"or noise in both platforms (but not between signal and noise).",
"Similar NPX ranges and sufficient counts provide additional insight into",
"an assay's bridgeability.",
"Distribution shape is assessed to determine recommended bridging method.", 
sep = " ")
```

\
\

Prior to assessment, outlier bridging samples are excluded. A sample is
considered an outlier if the NPX value is more than 3 times the
interquartile range above or below the median on either product.

After assessment, an assay is considered bridgeable if it meets the
first three criteria. The fourth criteria determines which normalization
method is recommended for bridging. If all four criteria are met then
the recommended method is normalization using the median of paired
differences. If only the first three criteria are met then quantile
smoothing is recommended. If any of the first three criteria are not met
then bridging is not recommended for that assay. Note that bridgeable
assays will differ between projects based on the expression of bridge
samples in the studies.

### Normalization using the median of paired differences

If it is expected that both the kind of distribution and the variance
per test between runs are the same, then normalization using the median
of paired differences will be preferred. Normalization using the median
of paired differences based on the bridging samples is performed in the
following steps:

1.  For each assay in the Explore 3072 project, the pairwise difference
    is calculated for each of the bridging samples with the Explore HT
    project.

2.  The normalization factor is estimated for each assay by finding the
    median of the pairwise differences.

3.  The assay-specific normalization factor for each assay is used to
    normalize each data point from Explore 3072 to Explore HT.

### Quantile smoothing

Since Explore HT and Explore 3072 are two distinct products with
different workflows involved in generating NPX data, some of the assays
exist in corresponding but distinct NPX spaces. For those assays, the
median of paired differences is insufficient for bridging as it only
considers one anchor point (the median/50% quantile). Instead, quantile
smoothing (QS) using multiple anchor points (5%, 10%, 25%, 50%, 75%, 90%
and 95% quantiles) is favored to map the Explore 3072 data to the
Explore HT distribution. The normalization using QS uses bridging samples
to perform the following steps:

1.  Each data point of the samples from Explore 3072 is mapped to the
    equivalent space in Explore HT using an empirical cumulative
    distribution function. An empirical cumulative distribution function
    is a probability model which uses the observed data, in this case
    the NPX values of the bridging samples for an assay, to create a step
    function which interpolates linearly between the available data
    points.

2.  The empirical distribution function is used to map the data points
    from Explore 3072 to the Explore HT space using the specified
    quantiles. At this point all data points from the bridging samples
    have NPX values that are normalized to the data points in Explore
    HT.

3.  To normalize the remaining data, a spline regression model is
    constructed using the sorted Explore 3072 data (prior to mapping) and the mapped
    Explore 3072 data, along with the anchor points of the spline
    function. A spline regression model divides a data set at the
    quantiles and uses the quantile as an anchor point or knot. Then a
    model is generated to fit the points between each anchor point.

4.  The spline regression model is then used to predict all the data
    points from Explore 3072 to Explore HT. The spline regression model
    results in a combination of linear regression models within
    intervals. The Explore 3072 NPX values are input as the x value
    within the corresponding interval, which results in a y value
    equivalent to the Explore HT NPX value.

### Function Output

The output from `olink_normalization()` function when used for between 
product bridging is a dataframe with concatenated data from the two products 
and additional columns including adjusted NPX values, bridging recommendations,
mapping information, and project names. The adjusted NPX values are notated in
the columns `MedianCenteredNPX` and `QSNormalizedNPX`. For each assay a
recommendation is listed in the `BridgingRecommendation` column and
lists what method, if any should be used for that assay. Additional
columns including `OlinkID` and `OlinkID_E3072` map the assays across
products and the `Project` column lists the name of the project based on
the `df1_project_nr` and `df2_project_nr` arguments. The resulting
data set will contain the newly bridged Explore 3072 data set. The
reference Explore HT data will be concatenated to the Explore 3072 data.
As the reference data is not altered during normalization, the
normalized NPX values in the Explore HT data will be the same as the
values in the NPX column which contains the non-normalized data.

```{r echo=FALSE}
try( 
  readRDS(normalizePath("../man/figures/bridging_results.rds")) |> 
    kableExtra::kbl(booktabs = TRUE,
        digits = 1,
        caption = "Table 4. First 5 rows of combined datasets after bridging.") |>
    kableExtra::kable_styling(bootstrap_options = "striped", full_width = FALSE, font_size = 10, 
                  position = "center", latex_options = "HOLD_position") |> 
    kableExtra::scroll_box(width = "100%")
)
```


## Evaluating the quality of bridging

PCA is used to assess the quality of bridging by determining if the
sample controls (SCs) and bridging samples appear closer after bridging.
Two PCAs can be generated, one containing the SCs and one containing the
bridging samples. Prior to bridging there will be a noticeable
separation between products which should decrease after bridging.

```{r include=FALSE}
f8 <- "Combined PCA of sample controls from both platforms prior to normalization."
f9 <- "Combined PCA of bridging samples from both platforms prior to normalization."
f10 <- "Combined PCA of sample controls from both platforms after normalization."
f11 <- "Combined PCA of bridging samples from both platforms after normalization."
```


```{r pca_pre_sc, echo=TRUE, eval = FALSE}
## Before Bridging
npx_br_data |> 
  dplyr::filter(SampleType == "SAMPLE_CONTROL") |> 
  dplyr::mutate(OlinkID = paste0(OlinkID, "_", OlinkID_E3072)) |> 
  dplyr:::mutate(SampleID = paste0(Project, SampleID)) |> 
  OlinkAnalyze::olink_pca_plot(color_g = "Project")
```

```{r pca_pre_sc_fig, echo=FALSE, fig.cap=f8, message=FALSE}
## Before Bridging
knitr::include_graphics(normalizePath("../man/figures/SCs_pre_bridging.png"), 
                        error = FALSE)
```

```{r pca_pre_bridge, echo=TRUE, eval=FALSE}
## Before Bridging
npx_br_data |> 
  dplyr::filter(SampleType == "SAMPLE") |> 
  dplyr::filter(SampleID %in% overlapping_samples) |> 
  dplyr::mutate(OlinkID = paste0(OlinkID, "_", OlinkID_E3072)) |> 
  dplyr:::mutate(SampleID = paste0(Project, SampleID)) |> 
  OlinkAnalyze::olink_pca_plot(color_g = "Project")
  

```

```{r echo=FALSE, fig.cap=f9}
knitr::include_graphics(normalizePath("../man/figures/bridges_pre_bridging.png"),
                        error = FALSE)
```


```{r eval = FALSE}
## After bridging PCA

### Keep the data following BridgingRecommendation
npx_after_br_reco <- npx_br_data |>
  dplyr::filter(BridgingRecommendation != "NotBridgeable") |>
  dplyr::mutate(NPX = case_when(
    BridgingRecommendation == "MedianCentering" ~ MedianCenteredNPX,
    BridgingRecommendation == "QuantileSmoothing" ~ QSNormalizedNPX,
    .default = NPX)) |>
  dplyr::filter(AssayType == "assay") |> 
  dplyr::mutate(OlinkID = paste0(OlinkID, "_", OlinkID_E3072))

```

``` {r pca_post_SC, eval=FALSE, echo = TRUE}

### Generate unique SampleIDs
npx_after_br_final <- npx_after_br_reco |>
  dplyr:::mutate(SampleID = paste0(Project, SampleID))
  
### PCA plot of the data from SCs
npx_after_br_final |> 
    dplyr::filter(SampleType == "SAMPLE_CONTROL") |> 
    OlinkAnalyze::olink_pca_plot(color_g = "Project")
  
```

```{r echo=FALSE, fig.cap=f10}
knitr::include_graphics(normalizePath("../man/figures/SCs_post_bridging.png"),
                        error = FALSE)
```


```{r echo=TRUE, eval = FALSE}
### PCA plot of the data from bridging samples
npx_after_br_reco |> 
  dplyr::filter(SampleType == "SAMPLE") |> 
  dplyr::filter(SampleID %in% overlapping_samples) |> 
  dplyr:::mutate(SampleID = paste0(Project, SampleID)) |> 
  OlinkAnalyze::olink_pca_plot(color_g = "Project")
```

```{r echo=FALSE, fig.cap=f11}
knitr::include_graphics(normalizePath("../man/figures/bridges_post_bridging.png"), 
                        error = FALSE)
```

## Exporting Normalized Data

The normalized Explore 3072 data can be exported using
`arrow::write_parquet()` to create a long format Olink Explore file.

```{r eval = FALSE}
df <- npx_br_data |>
    dplyr::filter(Project == "Explore_3072") |>
    arrow::as_arrow_table()

df$metadata$FileVersion <- "NA"
df$metadata$ExploreVersion <- "NA"
df$metadata$ProjectName <- "NA"
df$metadata$SampleMatrix <- "NA"
df$metadata$DataFileType <- "Olink Analyze Export File"
df$metadata$ProductType <- "Explore3072"
df$metadata$Product <- "Explore3072"
arrow::write_parquet(x = df, sink = "path_to_output.parquet")
```

## FAQs

### Overlapping Assays within products

Both the Explore 3072 and Explore HT products contain assays that appear
multiple times in the product, known as overlapping assays or
correlation assays. In Explore 3072, these present as overlapping assays
across panels. In Explore HT, these are overlapping assays across
blocks. These assays are included for QC purposes and allow users to
evaluate data performance across panels in Explore 3072 and across
blocks in Explore HT. Within each product, the assays contain unique OlinkID values for each of their corresponding panels and blocks in Explore 3072 and Explore HT,
respectively.

IL6, IL8 (CXCL8), and TNF are included in the
Cardiometabolic, Oncology, Neurology and Inflammation panels, while
IDO1, LMOD1, and SCRIB are included in the Cardiometabolic II, Oncology
II, Neurology II and Inflammation II panels. Each correlation assay is
measured four times in an Olink Explore 3072 run. In Explore HT, GBP1
and MAPK1 serve as overlapping assays and are measured three times in a
run.

### Downstream Analysis

Olink Analyze statistical analysis functions default to use the data in
the `NPX` column. This means that if the resulting data from the `olink_normalization()` function is used in a downstream analysis function, then the non-normalized NPX data will be used. To use the recommended normalized data, `dplyr::mutate()` can be used to reassign the NPX data. Additionally, to ensure that overlapping assays within products are analyzed individually, `OlinkID` can be temporarily assigned to the concatenated version of the OlinkIDs. This dataframe can then be used in any downstream analysis function within Olink Analyze. 

Assays which are not recommended for bridging should be analyzed separately and can be combined using a meta-analysis. Depending on the study design these assays can either be excluded from the downstream analysis or the assays can be treated as non-overlapping assays.

```{r echo=TRUE, eval=FALSE}
# Option 1: Exclude non bridgeable assays from both products
npx_recommended <- npx_after_br_final |> 
  dplyr::mutate(NPX_original = NPX) |> 
  dplyr::filter(BridgingRecommendation != "NotBridgeable") |>
  dplyr::mutate(NPX = case_when(
    BridgingRecommendation == "MedianCentering" ~ MedianCenteredNPX,
    BridgingRecommendation == "QuantileSmoothing" ~ QSNormalizedNPX,
    .default = NPX)) |> 
  dplyr::mutate(OlinkID_HT = OlinkID) |> 
  dplyr::mutate(OlinkID = paste0(OlinkID, "_", OlinkID_E3072))

# Option 2: Analyze non bridgeable assays separately
npx_recommended <- npx_after_br_final |> 
  dplyr::mutate(NPX_original = NPX) |> 
  dplyr::mutate(NPX = case_when(
    BridgingRecommendation == "MedianCentering" ~ MedianCenteredNPX,
    BridgingRecommendation == "QuantileSmoothing" ~ QSNormalizedNPX,
    .default = NPX)) |> 
  dplyr::mutate(OlinkID_HT = OlinkID) |> 
  dplyr::mutate(OlinkID = ifelse(BridgingRecommendation != "NotBridgeable",
                                 paste0(OlinkID, "_", OlinkID_E3072), 
                                 # Concatenated OlinkID for bridgeable Assays
                                 ifelse(Project == "Explore HT", 
                                        # replace with HT project name as set in function
                                        OlinkID, 
                                        OlinkID_E3072))
```



## Contact Us

We are always happy to help. Email us with any questions:

-   biostat\@olink.com for statistical services and general stats
    questions

-   support\@olink.com for Olink lab product and technical support

-   info\@olink.com for more information

## Legal Disclaimer

© 2024 Olink Proteomics AB.

Olink products and services are For Research Use Only and not for Use in
Diagnostic Procedures.

All information in this document is subject to change without notice.
This document is not intended to convey any warranties, representations
and/or recommendations of any kind, unless such warranties,
representations and/or recommendations are explicitly stated.

Olink assumes no liability arising from a prospective reader’s actions
based on this document.

OLINK, NPX, PEA, PROXIMITY EXTENSION, INSIGHT and the Olink logotype are
trademarks registered, or pending registration, by Olink Proteomics AB.
All third-party trademarks are the property of their respective owners.

Olink products and assay methods are covered by several patents and
patent applications <https://olink.com/legal/patents>.
